Cargando…
KIAA1199 overexpression is associated with abnormal expression of EMT markers and is a novel independent prognostic biomarker for hepatocellular carcinoma
PURPOSE: To determined KIAA1199 expression and investigate its correlation with the clinicopathologic data and prognosis of hepatocellular carcinoma (HCC), as well as markers of epithelial-mesenchymal transition (EMT); N-cadherin, E-cadherin and vimentin. MATERIALS AND METHODS: Western blot, quantit...
Autores principales: | Jiang, Zhengchen, Zhai, Xiangyu, Shi, Binyao, Luo, Dan, Jin, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260188/ https://www.ncbi.nlm.nih.gov/pubmed/30538502 http://dx.doi.org/10.2147/OTT.S187389 |
Ejemplares similares
-
Overexpression of KIAA1199 is an independent prognostic marker in laryngeal squamous cell carcinoma
por: Huang, Meixiang, et al.
Publicado: (2020) -
Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma
por: Zhai, Xiangyu, et al.
Publicado: (2020) -
Knockdown of KIAA1199 attenuates growth and metastasis of hepatocellular carcinoma
por: Liu, Jingmei, et al.
Publicado: (2018) -
Identification of KIAA1199 as a Biomarker for Pancreatic Intraepithelial Neoplasia
por: Suh, Han Na, et al.
Publicado: (2016) -
Overexpression of KIAA1199, a novel strong hyaluronidase, is a poor prognostic factor in patients with osteosarcoma
por: Ito, Kan, et al.
Publicado: (2021)